Ende Yang
Impact in
-
- Esophageal Cancer Research and Treatment
-
- Lung Cancer Diagnosis and Treatment
- Ferroptosis and cancer prognosis
Papers in
- Surgery 5
- Esophageal Cancer Research and Treatment 3
- Head and Neck Anomalies 2
- Teratomas and Epidermoid Cysts 2
-
- Cardiac tumors and thrombi 2
- Co-authors
- Yun Wang (1 shared paper)Hong Ren (1 shared paper)Bo Yang (1 shared paper)Qiang Lü (1 shared paper)Xueyong Li (1 shared paper)Pei Li (1 shared paper)Ying Han (1 shared paper)Xiang Ji (1 shared paper)
- Journals
- Pharmacogenomics and Personalized Medicine (2 papers)International Journal of Surgery (2 papers)Tumor Biology (1 paper)Diseases of the Esophagus (1 paper)JAMA Oncology (1 paper)
- Partner nations
- China
In The Last Decade
Ende Yang
11 papers receiving 326 citations
Ende Yang's Hit Papers
Peers
Comparison fields: 5 of 32
- Surgery 154
- Pulmonary and Respiratory Medicine 104
- Oncology 75
- Cancer Research 16
- Nutrition and Dietetics 10
Countries citing papers authored by Ende Yang
This map shows the geographic impact of Ende Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ende Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ende Yang more than expected).
Fields of papers citing papers by Ende Yang
This network shows the impact of papers produced by Ende Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ende Yang. The network helps show where Ende Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ende Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE) Hit paper breakdown → | 2022 | 162 |
| 2 | 2023 | 74 | |
| 3 | 2022 | 44 | |
| 4 | 2015 | 17 | |
| 5 | 2016 | 11 | |
| 6 | 2023 | 7 | |
| 7 | 2011 | 6 | |
| 8 | 2013 | 4 | |
| 9 | 2025 | 3 | |
| 10 | 2022 | 1 | |
| 11 | 2024 | 1 |
About Ende Yang
Ende Yang is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Nutrition and Dietetics and Cancer Research, having authored 11 papers that have together received 330 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (3 papers), Head and Neck Anomalies (2 papers), Teratomas and Epidermoid Cysts (2 papers), Cardiac tumors and thrombi (2 papers), Trace Elements in Health (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Inflammasome and immune disorders (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Surgery (154 citations), Pulmonary and Respiratory Medicine (104 citations), Oncology (75 citations), Cancer Research (16 citations) and Nutrition and Dietetics (10 citations). Ende Yang has collaborated with scholars based in China. Frequent co-authors include Yun Wang, Hong Ren, Bo Yang, Qiang Lü, Xueyong Li, Pei Li, Qiang Lü, Ying Han, Xiang Ji and Jinbo Zhao. Their work appears in journals such as Pharmacogenomics and Personalized Medicine, International Journal of Surgery, Tumor Biology, Diseases of the Esophagus and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.